ALA Supplementation Improves Inflammation, Mood Status in Women With Episodic Migraine
Researchers investigated the effect of alpha-lipoic acid (ALA) on oxidative, inflammatory, and mood conditions in women with episodic migraine.
All articles by Neurology Advisor Contributing Writer
Higher HDL and Apolipoprotein A1 Levels Tied to Reduced ALS Risk
Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.
Nonimmunogenic Staphylokinase Noninferior to Alteplase in Ischemic Stroke
Researchers assessed the safety and efficacy of nonimmunogenic recombinant staphylokinase compared with alteplase in patients with acute ischemic stroke within 4.5 hours following symptom onset.
Adherence to Atrial Fibrillation Pathway Improves Outcomes
Authors performed a systematic review of current evidence for the use of the Atrial Fibrillation Better Care (ABC) pathway and its effect on clinical outcomes.
Early Deficits of Cauda Equina Syndrome: A Case Study
A young man is diagnosed with cauda equina syndrome on his third visit to an emergency department. Early and late CES signs/symptoms are discussed in this case study
High Adolescent BMI Increases Stroke Risk in Young Adults With, Without Diabetes
The association between stroke and obesity in adolescence was examined in a population-based study.
Ponesimod Shown Promising for MRI Outcomes in Relapsing MS
Compared to teriflunomide, ponesimod showed benefit for magnetic resonance imaging (MRI) outcomes in relapsing multiple sclerosis.
Extended-Release Amantadine Improves Walking Speed in Patients With MS
ADS-5102, the extended release capsule form of amantadine, may clinically benefit walking speed in patients with multiple sclerosis.
Amiloride, Fluoxetine, Riluzole Do Not Reduce Atrophy Rates in Secondary Progressive MS
In secondary progressive multiple sclerosis, amiloride, fluoxetine, and rizuole treatments do not translate into long-term reduction in atrophy rates.
CSF UCH-L1 Biomarker Predictive of Long-Term Disease Progression in MS
Baseline levels of ubiquitin C-terminal hydrolase L1 in cerebral spinal fluid may be predictive of long term multiple sclerosis progression.
- Loading...
Loading...
Next post in MSVirtual2020
Loading... 
Loading...